Cancer Vaccine
Biomira Presents Additional MUC-1 Data at Vaccine Conference
Published in Cancer Weekly, March 2nd, 1998
Biomira Inc., Edmonton, Canada, presented pre-clinical data on BLP25 at IBC's Fifth International Conference on Vaccine Technologies in Washington, DC. Babita Agrawal, Ph.D., Head of Immunology Research at Biomira made the presentation on BLP25, which is the company's liposomal formulation of its MUC-1 peptide vaccine for the treatment of cancer. This data provides additional support for the rationale for moving BLP25 toward commercialization.
In a pre-clinical metastatic lung cancer model, developed by Biomira, where the cancer expresses human MUC-1 on the cell surface, BLP25 prevented the appearance of lung metastases when given in advance of the cancer cells;...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1998-03-02)
More Articles from Cancer Weekly
- Cancer Gene Therapy
Antisense Oligonucleotides Tested For Prostate Cancer Therapy - Cancer Gene Therapy
Combined Effects of p21 and p16 Transduction Studied In Vitro - Ribozyme Therapy
Hairpin Ribozymes Inhibit HPV-16 E6/E7 Immortalization of Normal Keratinocytes - Kaposi's Sarcoma Associated Herpesvirus
KSHV-GPCR Acts As Viral Oncogene to Transform NIH3T3 Cells - Transplantation (Umbilical Cord Blood)
Some CB T-cell Repertoire Features Are Similar to Those of Adults - Angiogenesis
Regulation Mechanism Suggests New Anti-Cancer Therapeutic Agents - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
